This Formulary Watch® Executive Brief is sponsored by Esperion.
Advancing Hyperlipidemia Management: Nonstatin Therapies in Guideline-Based Care
Trending on Managed Healthcare Executive
1
Sponsored: The Teva Biosimilars Trend Report
2
California PBM Law is a Starting Point for Real Transparency
3
Topical Ruxolitinib Cream Rapidly Repigments Vitiligo Lesions, Study Finds
4
FDA Accepts NDA for Investigational Maintenance Asthma Treatment
5
